Dioxo-triazines as a novel series of cathepsin K inhibitors
Rankovic, Z., Cai, J., Fradera, X., Dempster, M., Mistry, A., Mitchell, A., Long, C., Hamilton, E., King, A., Boucharens, S., Jamieson, C., Gillespie, J., Cumming, I., Uitdehaag, J., van Zeeland, M.(2010) Bioorg Med Chem Lett 20: 1488-1490
- PubMed: 20153187 
- DOI: https://doi.org/10.1016/j.bmcl.2010.01.116
- Primary Citation of Related Structures:  
3KWB - PubMed Abstract: 
A novel dioxo-triazine series of cathepsin K inhibitors was identified from HTS. A rapid exploratory programme led to the discovery of potent and selective cathepsin K inhibitors, typified by compound 24 which displayed IC(50) values of 17nM against catK and >10,000nM in catL, catB and catS assays.
Organizational Affiliation: 
Schering-Plough Corporation, Newhouse, Lanarkshire, ML1 5SH, Scotland, United Kingdom. zoran.rankovic@spcorp.com